Prospect Financial Group LLC

Position in ABBV — AbbVie Inc.

CIK 2021762 ARLINGTON, VA

Position in ABBV

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$286,617

+$52,816 QoQ

Shares Held

1,139

+6.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.65%

of 13F equity value

Holder Rank

#3,664

of 4,153 holders

Holding Since

Mar 2025

6 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Prospect Financial Group LLC holds $2,219,700 across 5 Drug Manufacturers - General names. ABBV ranks #5 (12.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	542	$650,091
2	JNJ	Johnson & Johnson	2,344	$595,305
3	MRK	Merck & Co., Inc.	2,699	$346,821
4	NVS	Novartis AG	2,175	$340,866
5	ABBV	AbbVie Inc. This page	1,139	$286,617

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$286,617	1,139	+6.0%	Shares	Sole	2026-08-07
2026-03-31	$233,801	1,075	-5.5%	Shares	Sole	2026-05-06
2025-12-31	$260,021	1,138	0.0%	Shares	Sole	2026-02-10
2025-09-30	$263,492	1,138	+0.2%	Shares	Sole	2025-11-06
2025-06-30	$210,864	1,136	+5.2%	Shares	Sole	2025-08-07
2025-03-31	$226,281	1,080	—	Shares	Sole	2025-05-07
No filing history on record for this holder in this stock.